Abstract The aim of this research was to produce novel antitumor fluoroquinolones from antibacterial analogs by introduction of a heterocyclic ring as a bioisostere of the C-3 carboxylic acid group. To this end, two series of eleven s-triazole derivatives bearing functionalized side chains of Schiff bases and Schiff-Mannich bases were designed and synthesized. Structures were characterized by elemental analysis and spectral data after which in vitro antitumor activity against L1210, CHO and HL60 cell lines was evaluated in the MTT assay. Compounds possessing a free phenol group were particularly active and warrant further development.
Introduction
Rational mechanism-based drug design is an efficient route for the discovery of lead compounds 1 . An interesting example is the use of prokaryotic type II topoisomerases (DNA gyrase and topoisomerase IV) and eukaryotic type II topoisomerases as cellular targets in the search for fluoroquinolones with antibacterial and anticancer activities respectively 2 . In view of the mechanistic similarity and sequence homologies of the two enzymes, many attempts have been made to modify antibacterial fluoroquinolones to produce novel antitumor drugs. 3, 4 . However, most of this research has focused on the C-7 piperazine ring of the fluoroquinolone skeleton 5 and little effort has been devoted to the C-3 carboxylic acid group. Recently, promising results of tests on compounds in which the carboxylic acid group is replaced with s-triazole and its fused heterocyclic ring have increased our interest in developing such compounds as antitumor fluoroquinolones 6, 7 . Because Schiff bases 8 and Mannich bases 9 are common pharmacophores in the design and development of anticancer chemotherapeutic agents, we now report the synthesis and antitumor activity of Schiff and Schiff-Mannich base-substituted derivatives of compounds produced by bioisosteric replacement of the C-3 carboxylic acid group in ofloxacin 1 with an s-triazole ring (Scheme 1).
Results and discussion
Ofloxacin hydrazide 2 was conveniently prepared by direct hydrazinolysis of ofloxacin 1. A direct condensation of hydrazide 2 with carbon disulfide in ethanol gave the corresponding hydrazide carbodithioic acid 3 in better yield than that produced in a general potassium hydroxide-catalyzed procedure 10 . The key intermediate, C-3-(1-amino-5-mercaptos-triazole) 4, was then successfully prepared by base-catalyzed cyclo-condensation of 3 with hydrazine hydrate. Schiff base reactions of 4 with aromatic aldehydes was carried out in glacial acetic acid to form the respective Schiff bases 5. Subsequent Mannich reactions with dimethylamine in glacial acetic acid gave the compounds 6 bearing both functionalized side chains of Schiff and Mannich bases.
The 1 H NMR spectra of 6a-6k displayed three characteristic one-proton signals at d 9.20-8.90 (s, 1H), 8.90 (s, 1H) and 5.20-5.10 (s, 1H) assigned to the 2-H of the fluoroquinolone scaffold, imino carbon-H of the Schiff-base (CH¼N) and methylene-H of the Mannich-base (N-CH 2 ), respectively. In addition, a peak at d 2.30 (s, 6H) was assigned to the dimethylamino carbon-H instead of the mercapto-H of 5 at d 13.70 (s, 1H). In the mass spectra of compounds 5 and 6, base peaks corresponded to the respective molecular ion peaks.
In vitro antitumor activity of compounds 5 and 6 against a murine leukemia cell line (L1210), a human leukocytoma cell line (HL60) and a Chinese hamster ovary cell line (CHO) was evaluated using the MTT assay 7 . The results show that compounds 6a-6k are significantly more cytotoxic (IC 50 values of 0.14-17.6 mM) than their parent Schiff bases 5a-5k (IC 50 values 10.5-50.2 mM) ( Table 1) . More interestingly, compounds 5c, 5g, 5h, 6c, 6g and 6h possessing a free phenol group exhibit more potent activity than the other tested compounds. These preliminary results suggest that replacement of the C-3 carboxylic group by a heterocycle modified by two functionalized pharmacophores (in this case Schiff and Mannich bases) is a promising strategy for the further development of fluoroquinolone anticancer agents.
Scheme 1 Synthetic route to Schiff (5a-5k) and Schiff-Mannich (6a-6k) base-substituted s-triazole derivatives of ofloxacin 1. R in 
Experimental

Chemistry
Melting points were determined in sealed capillaries and are uncorrected. IR spectra were recorded on a Nicolet Impact 410 spectrometer; 1 H NMR spectra on a Bruker AM-400 spectrometer; mass spectra on an Esquire LC instrument and elemental analyses on a PE 2400-II instrument. Materials and solvents were commercially available except where indicated and were used as received. 
A mixture of 4 (1.0 g, 2.3 mmol) and an aromatic aldehyde (2.5 mmol) in glacial acetic acid (15 mL) was refluxed for 24 h. After removal of the solvent under reduced pressure, the residue was dissolved in DMF-ethanol and the resulting precipitates Schiff bases 5a-5k were collected. 68 (s, 1H, SH), 9.16 (s, 1H, H-2 2 mmol) in methanol (10 mL) was refluxed for 1 h after which 37% formaldehyde (0.5 mL) was added and the mixture was refluxed for 12 h. After removal of solvent under reduced pressure, the residue was dissolved in water (10 mL), the pH was adjusted to pH 8.0 using ammonia and the liquid was extracted with chloroform. The dried extract was evaporated in vacuo and the residue was recrystallized from ethanol to give the Schiff-Mannich bases 6a-6k. 14 (s, 1H, H-2), 8.92 (s, 1H,  CH¼ N 
MTT assay
The tumor cell lines, L1210, HL60 and CHO were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum. Medium containing 5 Â 10 3 cells was seeded into each well of a 96-well microplate and the tested compounds were added at concentrations of 0.1, 1.0, 10.0, 30.0 and 50.0 mM to triplicate wells before making the final volume up to 100 mL. Plates were incubated at 37 1C for 48 h in a humidified atmosphere (5% CO 2 , 95% air) after which 100 mL methylthiazole trazolium (MTT) solution (1.0 mg/mL in phosphate-buffered saline lacking calcium and magnesium) was added to each well. After a further incubation for 4 h at 37 1C, 100 mL DMSO was added to wells containing CHO cells and 10% sodium dodecylbenzenesulfonate was added to wells containing L1210 and HL60 cells to solubilize any MTTformazan produced. The optical density (OD) of each well was measured at 570 nm (OD 570 ) with a microplate reader and the inhibition of cell growth was calculated as (1ÀT/C) Â 100%, where C is the mean OD 570 of the control group and T is that of the treated group. The IC 50 was determined from the concentration-response data.
